TARA FY 2019 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$211M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$16,000

Operating Income

-$15M

Net Income

-$15M

EPS (Diluted)

$-3.63

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$943,000

Balance Sheet

Total Assets

$7M

Total Liabilities

$583,000

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$16,000	-$115,000	+86.1%
Operating Income	-$15M	-$26M	+41.5%
Net Income	-$15M	-$25M	+41.1%